Retinal Pharmaceuticals is primarily used to treat retinal-related diseases.
Retina is a layer of nerve tissue lining the back of the eye. Retina receives light and convert it into neural signals, and send these signals to the brain for visual recognition. The central part of the retina is known as macula, which is responsible for central vision. The remaining tissue outside the macula is responsible for peripheral vision. There are many types of retinal diseases.
This report contains market size and forecasts of Retinal Pharmaceuticals in global, including the following market information:
Global Retinal Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Retinal Pharmaceuticals Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Retinal Pharmaceuticals companies in 2021 (%)
The global Retinal Pharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Macular Degeneration Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Retinal Pharmaceuticals include Santen Pharmaceutical Co.，Ltd., Regeneron Pharmaceuticals，Inc., Takeda, Bayer AG, Novartis International AG, Valeant Pharmaceuticals International，Inc and Merck＆Co., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retinal Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Retinal Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Macular Degeneration
Diabetic Eye Disease
Retinal Detachment
Retinoblastoma
Macular Pucker
Macular Hole
Others
Global Retinal Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Retinal Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies
Global Retinal Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Retinal Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinal Pharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Retinal Pharmaceuticals revenues share in global market, 2021 (%)
Key companies Retinal Pharmaceuticals sales in global market, 2017-2022 (Estimated), (MT)
Key companies Retinal Pharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Santen Pharmaceutical Co.，Ltd.
Regeneron Pharmaceuticals，Inc.
Takeda
Bayer AG
Novartis International AG
Valeant Pharmaceuticals International，Inc
Merck＆Co.